Corrado Santocanale Selected Research

PHA 767491

7/2013	Characterization of a Dual CDC7/CDK9 Inhibitor in Multiple Myeloma Cellular Models.
6/2008	A Cdc7 kinase inhibitor restricts initiation of DNA replication and has antitumor activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Corrado Santocanale Research Topics

Disease

7	Neoplasms (Cancer) 10/2018 - 01/2007
2	Ataxia Telangiectasia (Louis Bar Syndrome) 10/2013 - 04/2006
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2013 - 09/2011
1	Genomic Instability 12/2020
1	Chromosome Breakage 01/2020
1	Hypersensitivity (Allergy) 01/2016
1	Multiple Myeloma 07/2013
1	Tauopathies 07/2011

Drug/Important Bio-Agent (IBA)

6	Phosphotransferases (Kinase)IBA 01/2020 - 04/2006
3	Pharmaceutical PreparationsIBA 01/2016 - 09/2011
2	PHA 767491IBA 07/2013 - 06/2008
1	Ubiquitin-Specific ProteasesIBA 12/2020
1	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2016
1	Deubiquitinating EnzymesIBA 01/2016
1	7-hydroxystaurosporine (UCN 01)IBA 10/2013
1	Phosphatidylinositols (Phosphatidylinositol)IBA 10/2013
1	Bortezomib (Velcade)FDA Link 07/2013
1	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2013
1	Melphalan (Alkeran)FDA LinkGeneric 07/2013
1	Retinoblastoma ProteinIBA 07/2011
1	Small Interfering RNA (siRNA)IBA 10/2010

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 10/2018
1	Therapeutics 07/2009